HGF precursor protein variant and active protein thereof
AssigneesKringle Pharma Inc., Osaka University
InventorsToshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta, Kiichi Adachi, Daichika Hayata
Life of this patent
Estimating the term…
Loading patent…
AssigneesKringle Pharma Inc., Osaka University
InventorsToshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta, Kiichi Adachi, Daichika Hayata
Estimating the term…
An HGF precursor protein variant, in which a peptide structure comprises a sequence including a peptide chain X inserted between an α chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the C-terminus of the α chain are deleted, and a β chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the N-terminus of the β chain are deleted; wherein (i) the peptide chain X has an amino-acid sequence of at least two residues, (ii) the peptide chain X can be cleaved by a protease reaction or a chemical reaction, and (iii) a protein obtained by cleaving at least one site of the peptide chain X has HGF action.
A hepatocyte growth factor (HGF) precursor protein variant having an α-chain and a β-chain, in which amino acids in the HGF precursor protein variant are substituted with at least one protease recognition sequence, wherein the protein obtained by cleavage at said at least one protease recognition sequence results in a protein having hepatocyte proliferation activity;
Dependencies are inferred from the claim text.